Home/Filings/4/0001213900-25-043621
4//SEC Filing

Marques Tiago 4

Accession 0001213900-25-043621

CIK 0001841330other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 9:55 PM ET

Size

5.2 KB

Accession

0001213900-25-043621

Insider Transaction Report

Form 4
Period: 2025-05-12
Marques Tiago
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-05-12$0.82/sh960$79240,001 total
Footnotes (1)
  • [F1]The Reporting Person previously held 960 shares of Common Stock of the Issuer in a foreign brokerage account that was recently wound down. As a result, the foreign broker automatically liquidated the Reportion Person's account on May 12, 2025 by selling the 960 shares of Common Stock of the Issuer on a non-discretionary basis.

Documents

1 file

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

Related Parties

1
  • filerCIK 0001875240

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 9:55 PM ET
Size
5.2 KB